Anti-peptide antibodies, anti-SNRK and anti-HUWE1 antibodies as potential predictors of good response to tofacitinib therapy in rheumatoid arthritis patients
We identify two peptide antibodies, anti-SNRK and anti-HUWE1 antibodies, as pretreatment predictors of good therapeutic response to tofacitinib in RA patients.
Authors
- Jeremy J.W. Chen (ORCID: https://orcid.org/0000-0003-1049-3825)
- Po‐Ku Chen (ORCID: https://orcid.org/0000-0001-9628-2783)
- Yi‐Ming Chen (ORCID: https://orcid.org/0000-0001-7593-3065)
- Der‐Yuan Chen (ORCID: https://orcid.org/0000-0003-1266-1423)
Institutions
- National Yang Ming Chiao Tung University (TW)
- National Chung Hsing University (TW)
- China Medical University (TW)
- Taichung Veterans General Hospital (TW)
- China Medical University Hospital (TW)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1093/rheumatology/keae595
- Citations
- 1
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Ministry of Science and Technology
- China Medical University Hospital